FolioFact
Sign in

Duquesne Family Office — PTGX

How Duquesne Family Office's position in PROTAGONIST THERAPEUTICS INC changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing.

Quarter Shares Value % of portfolio Change
Q1 2026 159,700 $16,832,000 0.57%
Q4 2025 159,700 $13,948,000 0.33% NEW